CBO notes that some analyses of weight loss via GLP-1s found they reduced all-cause mortality in certain patients, while other methods had mixed results notably bariatric surgery, which did not clearly lower future health spending and was heavily dependent on individual adherence to post-surgery lifestyle changes
Always dissolve the powder by gently rolling or swirling the vial
Wegovy, Mounjaro vs
Eli Lillys GLP-1 offering, tirzepatide, launched shortly after (as Mounjaro for T2D in 2022 and Zepbound for obesity in 2023), demonstrated greater HbA1c reduction and up to a 20% placebo-adjusted weight loss
Safia Pirani, MD, monitor each patients response by reviewing changes in symptoms, energy levels, concentration, numbness or tingling, and overall well-being
Every protocol includes a clinical consultation, structured dosing cycles, and ongoing monitoring